查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613164

全球显影剂市场（按类型、治疗、给药途径、应用、最终用户、适应症）：未来预测（2025-2030）

Contrast Media Market by Type, Procedure, Route Of Administration, Application, End-user, Disease Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年显影剂市值为36.7亿美元，预计2024年将达到40.2亿美元，复合年增长率为9.75%，到2030年将达到70.4亿美元。

造影显影剂是医疗图像中必不可少的试剂，可提高体内结构和液体的可见度，并在 X 光、MRI 和电脑断层扫描等诊断过程中发挥重要作用。对这种药物的需求源于它能够提供清晰、详细的影像并帮助准确诊断和管理各种医疗状况。最终用途广泛，包括医院、诊断影像中心和专科诊所，并用于从放射学、循环系统学到胃肠道成像的各种医疗领域。

主要市场统计
基准年[2023] 36.7亿美元
预测年份 [2024] 40.2亿美元
预测年份 [2030] 70.4亿美元
复合年增长率（%） 9.75%

显影剂市场受到多种成长要素的影响，包括慢性病的增加、影像技术的进步以及需要频繁诊断影像的老年人口的增加。机会包括开发更安全、更有效的显影剂、针对特定医疗应用的技术创新以及增强的诊断影像技术。公司应探索新兴市场的潜力，这些市场是由医疗基础设施改善和对早期诊断益处的认识不断提高所推动的。

然而，市场面临显影剂副作用风险、严格的监管核准以及与先进诊断影像相关的高成本等挑战。解决这些限制需要对研究和开发进行投资，以提高药物的安全性和具有成本效益的解决方案。

创新和研发的机会在于开发副作用较少的新型生物相容性显影剂，以及研究减少传统药物所需剂量的成像技术。此外，探索人工智慧整合影像分析可以提高诊断准确性和业务效率。根据精准医疗的趋势，产业相关人员应专注于个人化医疗方法，根据个别患者的需求设计药物。儘管面临挑战，显影剂市场仍将带来巨大的成长机会，持续的技术和产品进步将推动未来的机会。公司需要策略性地了解这些趋势，以利用成长潜力，同时应对复杂的市场动态。

市场动态：揭示快速发展的显影剂市场的关键市场洞察

供需的动态交互作用正在改变显影剂市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 癌症和心血管疾病盛行率上升
    • 消费者对先进影像技术的偏好日益增长
    • 医疗基础建设投资快速成长
  • 市场限制因素
    • 研究开发更安全、更有效的显影剂高成本
  • 市场机会
    • 加大新型显影剂的创新与开发力度
    • 扩大在影像诊断中表现出优异性能的奈米粒子的开发
  • 市场挑战
    • 由于显影剂的潜在副作用，人们越来越担心患者的安全

波特的五力：驾驭显影剂市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。它为评估公司的竞争力和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解显影剂市场的外部影响

外部宏观环境因素对显影剂市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解显影剂市场的竞争格局

显影剂市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：显影剂市场供应商的绩效评估

FPNV定位矩阵是评估显影剂市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製显影剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，显影剂市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估市场范围和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析最近的产品发布、开拓的地区、关键产业进展以及塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1. 目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 哪些收益来源和策略机会推动供应商的进入/退出策略？

目录

第一章简介

第二章 分析方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症和心血管疾病的发生率上升
      • 消费者对先进影像技术的偏好日益增长
      • 医疗基础建设投资快速成长
    • 抑制因素
      • 研发更安全、更有效的显影剂高成本
    • 机会
      • 加大新型显影剂的创新与开发力度
      • 在成像过程中具有卓越性能的奈米粒子的开发进展
    • 任务
      • 由于显影剂的潜在副作用，增加了患者安全问题
  • 市场区隔分析
    • 类型：对准确诊断方法的需求增加了碘造影显影剂的使用
    • 应用：介入性放射线显影剂采用率高
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 经济因素
    • 社会因素
    • 技术因素
    • 法律因素
    • 环境因素

第六章显影剂市场：依类型

  • 钡基显影剂
  • 钆基显影剂
  • 显影剂
  • 微气泡显影剂

第七章显影剂市场：依程序

  • 磁振造影
  • 超音波
  • X 光与电脑断层扫描

第八章比较显影剂市场：依管理途径

  • 血管内给药
  • 口服给药
  • 直肠途径

第九章显影剂市场：依应用分类

  • 介入性心臟病学
  • 介入放射学
  • 放射治疗

第 10 章比较显影剂市场：依最终用户划分

  • 门诊手术中心
  • 影像诊断中心
  • 医院/诊所

第十一章显影剂市场：依适应症分类

  • 癌症
  • 心血管疾病
  • 胃肠道疾病
  • 肌肉骨骼疾病
  • 肾臟疾病
  • 神经系统疾病

第十二章美洲显影剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太显影剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第14章欧洲、中东和非洲显影剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • 费森尤斯卡比 (Fresenius Kabi) 推出新型非专利MRI显影剂
    • Imagion 扩大与西门子在 MRI显影剂的合作关係
    • GE Medical 推出 MRI 试剂 Pixxoscan（钆布醇），扩大显影剂组合
  • 战略分析和建议

公司名单

  • Acro Lifesciences (I) Pvt. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Spa
  • Covis Group
  • Daiichi Sankyo Co. Ltd.
  • Fuji Pharma Co. Ltd.
  • GE Healthcare Co., Ltd.
  • Guerbet SA
  • iMAX Diagnostic Imaging Limited
  • JB Chemicals & Pharmaceuticals Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • M.Biotech Limited
  • Miltenyi Biotec BV & Co. KG
  • Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • nanoPET Pharma GmbH
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • Vitalquan, LLC
Product Code: MRR-434CCDA04E9E

The Contrast Media Market was valued at USD 3.67 billion in 2023, expected to reach USD 4.02 billion in 2024, and is projected to grow at a CAGR of 9.75%, to USD 7.04 billion by 2030.

Contrast media, essential agents in medical imaging, enhance the visibility of structures and fluids within the body, playing a crucial role in diagnostic procedures such as X-rays, MRI, and CT scans. The necessity of these agents stems from their ability to provide clear, detailed images, aiding in the accurate diagnosis and management of various medical conditions. They find applications across diverse medical fields, from radiology and cardiology to gastrointestinal imaging, with end-use spanning hospitals, diagnostic imaging centers, and specialized clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.67 billion
Estimated Year [2024] USD 4.02 billion
Forecast Year [2030] USD 7.04 billion
CAGR (%) 9.75%

The contrast media market is influenced by several growth factors, including the increasing prevalence of chronic diseases, advancements in imaging technology, and the rising geriatric population necessitating frequent diagnostic imaging. Opportunities arise from the development of safer, more effective contrast agents and innovations targeting specific medical applications and enhanced imaging techniques. Companies should explore the potential in emerging markets, driven by healthcare infrastructure improvements and increasing awareness of early diagnosis benefits.

However, the market faces challenges such as the risk of adverse reactions to contrast media, stringent regulatory approvals, and high costs associated with advanced imaging procedures. Addressing these limitations requires investment in research and development to enhance agent safety profiles and cost-effective solutions.

Innovation and research opportunities lie in the development of novel, biocompatible contrast agents with minimal side effects, as well as the investigation of imaging techniques that reduce the required doses of traditional agents. Additionally, exploring AI integration for image analysis can improve diagnostic accuracy and operational efficiency. Industry players should focus on personalized medicine approaches, designing agents tailored to individual patient needs, aligning with the trend toward precision healthcare. Despite challenges, the contrast media market presents substantial growth prospects, with ongoing technological and product advancements driving future opportunities. Businesses must strategically align themselves with these trends to capitalize on growth potential while navigating complex market dynamics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contrast Media Market

The Contrast Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer and cardiovascular diseases
    • Increasing consumer preference toward advanced imaging technologies
    • Burgeoning investment in healthcare infrastructure
  • Market Restraints
    • High costs associated with research and development of safer and more effective contrast agents
  • Market Opportunities
    • Increasing innovations and development of new contrast agents
    • Growing development of nanoparticles offering superior performance in imaging procedures
  • Market Challenges
    • Rising patient safety concerns due to potential adverse reactions to contrast agents

Porter's Five Forces: A Strategic Tool for Navigating the Contrast Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contrast Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contrast Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contrast Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contrast Media Market

A detailed market share analysis in the Contrast Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contrast Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contrast Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contrast Media Market

A strategic analysis of the Contrast Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the Contrast Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Barium-Based Contrast Media, Gadolinium-Based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media.
  • Based on Procedure, market is studied across Magnetic Resonance Imaging, Ultrasound, and X-ray & Computed Tomography.
  • Based on Route Of Administration, market is studied across Intravascular Route, Oral Route, and Rectal Route.
  • Based on Application, market is studied across Interventional Cardiology, Interventional Radiology, and Radiology.
  • Based on End-user, market is studied across Ambulatory Surgery Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.
  • Based on Disease Indication, market is studied across Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and cardiovascular diseases
      • 5.1.1.2. Increasing consumer preference toward advanced imaging technologies
      • 5.1.1.3. Burgeoning investment in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development of safer and more effective contrast agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing innovations and development of new contrast agents
      • 5.1.3.2. Growing development of nanoparticles offering superior performance in imaging procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Rising patient safety concerns due to potential adverse reactions to contrast agents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities
    • 5.2.2. Application: High adoption of contrast media in interventional radiology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contrast Media Market, by Type

  • 6.1. Introduction
  • 6.2. Barium-Based Contrast Media
  • 6.3. Gadolinium-Based Contrast Media
  • 6.4. Iodinated Contrast Media
  • 6.5. Microbubble Contrast Media

7. Contrast Media Market, by Procedure

  • 7.1. Introduction
  • 7.2. Magnetic Resonance Imaging
  • 7.3. Ultrasound
  • 7.4. X-ray & Computed Tomography

8. Contrast Media Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Intravascular Route
  • 8.3. Oral Route
  • 8.4. Rectal Route

9. Contrast Media Market, by Application

  • 9.1. Introduction
  • 9.2. Interventional Cardiology
  • 9.3. Interventional Radiology
  • 9.4. Radiology

10. Contrast Media Market, by End-user

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals & Clinics

11. Contrast Media Market, by Disease Indication

  • 11.1. Introduction
  • 11.2. Cancer
  • 11.3. Cardiovascular Disorders
  • 11.4. Gastrointestinal Disorders
  • 11.5. Musculoskeletal Disorders
  • 11.6. Nephrological Disorders
  • 11.7. Neurological Disorders

12. Americas Contrast Media Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contrast Media Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contrast Media Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Fresenius Kabi Debuts New Generic MRI Contrast Agent
    • 15.3.2. Imagion Expands Collaboration With Siemens On MRI Contrast Agent
    • 15.3.3. GE HealthCare Expands Contrast Media Portfolio with Launch of MRI Agent Pixxoscan (gadobutrol)
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acro Lifesciences (I) Pvt. Ltd.
  • 2. Bayer AG
  • 3. Beijing Beilu Pharmaceutical Co., Ltd.
  • 4. Bracco Spa
  • 5. Covis Group
  • 6. Daiichi Sankyo Co. Ltd.
  • 7. Fuji Pharma Co. Ltd.
  • 8. GE Healthcare Co., Ltd.
  • 9. Guerbet SA
  • 10. iMAX Diagnostic Imaging Limited
  • 11. J. B. Chemicals & Pharmaceuticals Limited
  • 12. Jodas Expoim Pvt. Ltd.
  • 13. Lantheus Medical Imaging, Inc.
  • 14. M.Biotech Limited
  • 15. Miltenyi Biotec B.V. & Co. KG
  • 16. Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • 17. nanoPET Pharma GmbH
  • 18. SANOCHEMIA Pharmazeutika GmbH
  • 19. Spago Nanomedical AB
  • 20. Trivitron Healthcare
  • 21. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. CONTRAST MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRAST MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRAST MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023